Prosoma
The world’s first digital therapeutics programme, designed specifically for cancer patients
Prosoma has raised €3.3M across 3 funding rounds from 6 investors, most recently a round in Jun 2025. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.prosoma.com ↗
Total raised
€3.3M
€3,288,530
Funding rounds
3
Investors
6
distinct backers
Active since
2019-04
latest 2025-06
Funding by year
EUR raised per yearProsoma — funding by year — interactive chart.
Data table
| Prosoma — funding by year | |
|---|---|
| 2019 | €279k |
| 2022 | €3.0M |
| 2025 | €0 |
Signals
High confidenceRaise-next likelihood48
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
- ▲ 7y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-20 | Other | — | CRB Inverbío SGEIC,Impact Partners,Verge Fund | View deal → |
| 2022-12-22 | Other | €3.0M | Simpact Ventures,YouNick Mint | View deal → |
| 2019-04-01 | Other | €279k | Black Pearls VC | View deal → |